Nutraceutical potential of caprine milk products: emerging cardiometabolic health perspectives
Highlights
- •Caprine dairy products are a rich source of bioactive peptides and lipids.
- •Emerging evidence suggests cardiometabolic and anti-inflammatory benefits.
- •Robust, adequately powered trials are needed to establish health associations.
Abstract
Recent research trends indicate that dairy products may have several cardiometabolic health benefits, contrary to previous beliefs.
Epidemiological studies, including the Prospective Urban Rural Epidemiology (PURE) study, have associated greater than 2 servings of overall dairy/day with a 22% lower relative risk of major CVD events versus non consumers.
In this context, moderate consumption of dairy product has increased over the years due to their purported nutritional value.
While considerable research has focused on bovine milk products and their development into cardiometabolic functional foods and nutraceuticals, there has been an effort to expand into goat dairy product research.
Goat dairy products are widely consumed in the Mediterranean, Middle Eastern, and African nations, which has been associated with favourable health outcomes such as improvements in inflammatory markers, blood pressure, and glycaemic response.
These effects are attributed to goat’s milk components including peptides and bioactive lipids exhibiting potential anti-inflammatory and cardioprotective effects in experimental studies.
However, human studies are limited with clinical studies generally involving fewer than 60 participants, which remains a major gap in the literature.
Goat’s milk and dairy products are growing in popularity in Europe and North America beyond their artisan product status. Despite their popularity, research on goat dairy products has lagged behind bovine dairy research.
This narrative review critically appraises the emerging research on the nutritional value of goat dairy products and their potential use in functional foods and nutraceuticals for cardiometabolic health.

No comments:
Post a Comment